Search Results 331-340 of 17415 for alopecia
Low-grade (< Grade 3) toxicities, such as neuropathy from prior treatments, manageable electrolyte abnormalities and lymphopenia, alopecia and vitiligo are ...
World Lymphoma Day is September 15 ROCHESTER, Minnesota — For many doctors and researchers, immunotherapy that uses someone's own immune system to target ...
DEAR MAYO CLINIC: I have high blood pressure and was just diagnosed as having chronic kidney disease. I am disheartened by this news, but I[...] ...
When it comes to back pain, there's good news and bad news. The good news is that back pain is rarely a sign of something[...] ...
2024 marks a pivotal year for advancing artificial intelligence (AI) solutions in healthcare, requiring multidisciplinary teamwork and scientific rigor to ...
Participation eligibility · Exceptions: Neuropathy, fatigue, and/or alopecia may be Grade 1. · Known active central nervous system (CNS) metastases. NOTE: ...
Description. Upadacitinib is used to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, ...
The burden of cancer is different for everyone, and life stages can play a role in how it affects people. For adolescents and young adults[...] ...
As a summer surge of COVID-19 outbreaks is underway, new vaccines for the virus have been released. The Food and Drug Administration (FDA) approved new ...
03) except for subjects with alopecia; subjects receiving luteinizing hormone-releasing hormone agonists may be considered for enrollment after discussion with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.